SRTS Sensus Healthcare Inc revenue, earnings and financials
For the quarter ended June 30, 2026, Sensus Healthcare Inc reported revenue of $2.29M (down 68.7% from a year earlier), net income of −$8.75M and diluted EPS of −$0.53; over the last four quarters revenue was $17.5M and net income −$15.5M; for the fiscal year ended December 2025 revenue was $27.5M, down 34.3% on the year before.
SRTS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $27.5M, gross profit $11.9M, operating income −$10.3M, net income −$7.72M (margin -28.1%), EPS −$0.47
- Fiscal year ended Dec 2024: revenue $41.8M, gross profit $24.4M, operating income $8.09M, net income $6.65M (margin 15.9%), EPS $0.41
- Fiscal year ended Dec 2023: revenue $24.4M, gross profit $14.1M, operating income −$382K, net income $485K (margin 2.0%), EPS $0.03
- Fiscal year ended Dec 2022: revenue $44.5M, gross profit $29.6M, operating income $14.8M, net income $24.2M (margin 54.4%), EPS $1.46
- Fiscal year ended Dec 2021: revenue $27.0M, gross profit $17.0M, operating income $4.12M, net income $4.12M (margin 15.2%), EPS $0.25
SRTS quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $2.29M (down 68.7% year over year), net income −$8.75M, EPS −$0.53
- Quarter ended Mar 31, 2026: revenue $3.39M (down 59.3% year over year), net income −$2.63M, EPS −$0.16
- Quarter ended Dec 31, 2025 (from the annual report): revenue $4.94M (down 62.2% year over year), net income −$3.17M, EPS −$0.19
- Quarter ended Sep 30, 2025: revenue $6.88M (down 22.1% year over year), net income −$943K, EPS −$0.06
- Quarter ended Jun 30, 2025: revenue $7.32M (down 20.8% year over year), net income −$1.04M, EPS −$0.06
- Quarter ended Mar 31, 2025: revenue $8.34M (down 21.7% year over year), net income −$2.57M, EPS −$0.16
- Quarter ended Dec 31, 2024 (from the annual report): revenue $13.1M (up 4.0% year over year), net income $1.55M, EPS $0.10
- Quarter ended Sep 30, 2024: revenue $8.84M (up 126.8% year over year), net income $1.22M, EPS $0.07
- Quarter ended Jun 30, 2024: revenue $9.24M (up 104.1% year over year), net income $1.61M, EPS $0.10
- Quarter ended Mar 31, 2024: revenue $10.7M (up 212.3% year over year), net income $2.27M, EPS $0.14
- Quarter ended Dec 31, 2023 (from the annual report): revenue $12.6M (down 4.1% year over year), net income $4.21M, EPS $0.26
- Quarter ended Sep 30, 2023: revenue $3.90M (down 56.7% year over year), net income −$1.45M, EPS −$0.09
- Quarter ended Jun 30, 2023: revenue $4.53M (down 62.5% year over year), net income −$380K, EPS −$0.02
- Quarter ended Mar 31, 2023: revenue $3.41M (down 67.0% year over year), net income −$1.89M, EPS −$0.12
- Quarter ended Dec 31, 2022 (from the annual report): revenue $13.1M (up 0.6% year over year), net income $2.83M, EPS $0.17
- Quarter ended Sep 30, 2022: revenue $9.01M (up 63.1% year over year), net income $1.83M, EPS $0.11
- Quarter ended Jun 30, 2022: revenue $12.1M (up 122.8% year over year), net income $3.52M, EPS $0.21
- Quarter ended Mar 31, 2022: revenue $10.3M (up 236.7% year over year), net income $16.1M, EPS $0.97
- Quarter ended Dec 31, 2021 (from the annual report): revenue $13.0M, net income $5.32M, EPS $0.33
- Quarter ended Sep 30, 2021: revenue $5.53M, net income $195K, EPS $0.01
SRTS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $528K, share buybacks $300K
- Fiscal year ended Dec 2024: operating cash flow −$831K, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$2.15M, share buybacks $27.0K
- Fiscal year ended Dec 2022: operating cash flow −$1.41M, share buybacks $3.00M
- Fiscal year ended Dec 2021: operating cash flow −$286K, share buybacks n/a
SRTS balance sheet
- Jun 30, 2026: cash $15.2M, total assets $41.3M, total liabilities $4.40M, shareholders' equity $36.9M
- Mar 31, 2026: cash $18.3M, total assets $51.5M, total liabilities $6.00M, shareholders' equity $45.5M
- Dec 31, 2025: cash $22.1M, total assets $53.0M, total liabilities $4.94M, shareholders' equity $48.1M
- Sep 30, 2025: cash $24.5M, total assets $58.3M, total liabilities $7.10M, shareholders' equity $51.2M
- Jun 30, 2025: cash $22.2M, total assets $58.9M, total liabilities $6.79M, shareholders' equity $52.1M
- Mar 31, 2025: cash $19.1M, total assets $60.2M, total liabilities $7.18M, shareholders' equity $53.0M
- Dec 31, 2024: cash $22.1M, total assets $62.2M, total liabilities $6.34M, shareholders' equity $55.8M
- Sep 30, 2024: cash $22.6M, total assets $59.9M, total liabilities $5.73M, shareholders' equity $54.1M
What is SRTS's revenue?
Sensus Healthcare Inc reported $17.5M of revenue over its last four quarters, through June 30, 2026.
Is SRTS profitable?
No. Sensus Healthcare Inc lost $15.5M over the last four quarters.
What is SRTS's EPS?
Diluted earnings per share over the last four quarters were −$0.94; −$0.53 in the latest quarter.